サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1120320

世界の前頭側頭障害治療市場：考察と予測 (2028年まで)

Global Frontotemporal Disorders Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 100 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の前頭側頭障害治療市場：考察と予測 (2028年まで)
出版日: 2022年08月30日
発行: QYResearch
ページ情報: 英文 100 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、前頭側頭障害治療 (Frontotemporal Disorders Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の前頭側頭障害治療の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Cognitive Enhancers
    • Antipsychotics
    • Antidepressants
    • CNS Stimulants
    • Others
  • 市場：アプリケーション別
    • 世界の前頭側頭障害治療の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の前頭側頭障害治療の市場展望 (2017-2028)
  • 前頭側頭障害治療の市場成長トレンド：地域別
    • 前頭側頭障害治療 市場規模：地域別: 2017 VS 2021 VS 2028
    • 前頭側頭障害治療の市場規模実績：地域別 (2017-2022)
    • 前頭側頭障害治療の市場規模予測：地域別 (2023-2028)
  • 前頭側頭障害治療 市場動向
    • 前頭側頭障害治療 業界動向
    • 前頭側頭障害治療 市場の促進要因
    • 前頭側頭障害治療 市場の課題
    • 前頭側頭障害治療 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の前頭側頭障害治療の上位企業：収益別
    • 世界の前頭側頭障害治療の上位企業：収益別 (2017-2022)
    • 世界の前頭側頭障害治療の収益シェア：企業別 (2017-2022)
  • 世界の前頭側頭障害治療の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：前頭側頭障害治療の収益
  • 世界の前頭側頭障害治療 市場集中度
    • 世界の前頭側頭障害治療 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 前頭側頭障害治療の収益 2021
  • 前頭側頭障害治療の主要企業の本社および事業エリア
  • 主要企業 前頭側頭障害治療の製品ソリューションおよびサービス
  • 市場参入時期： 前頭側頭障害治療 市場
  • M&A, 拡張計画

第4章 前頭側頭障害治療 内訳データ：タイプ別

  • 世界の前頭側頭障害治療の市場規模実績：タイプ別 (2017-2022)
  • 世界の前頭側頭障害治療の市場規模予測：タイプ別 (2023-2028)

第5章 前頭側頭障害治療 内訳データ：アプリケーション別

  • 世界の前頭側頭障害治療の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の前頭側頭障害治療の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の前頭側頭障害治療 市場規模 (2017-2028)
  • 北米の前頭側頭障害治療 市場規模：タイプ別
    • 北米の前頭側頭障害治療 市場規模：タイプ別 (2017-2022)
    • 北米の前頭側頭障害治療 市場規模：タイプ別 (2023-2028)
    • 北米の前頭側頭障害治療の市場シェア：タイプ別 (2017-2028)
  • 北米の前頭側頭障害治療 市場規模：アプリケーション別
    • 北米の前頭側頭障害治療 市場規模：アプリケーション別 (2017-2022)
    • 北米の前頭側頭障害治療 市場規模：アプリケーション別 (2023-2028)
    • 北米の前頭側頭障害治療の市場シェア：アプリケーション別 (2017-2028)
  • 北米の前頭側頭障害治療 市場規模：国別
    • 北米の前頭側頭障害治療 市場規模：国別 (2017-2022)
    • 北米の前頭側頭障害治療 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の前頭側頭障害治療 市場規模 (2017-2028)
  • 欧州の前頭側頭障害治療 市場規模：タイプ別
    • 欧州の前頭側頭障害治療 市場規模：タイプ別 (2017-2022)
    • 欧州の前頭側頭障害治療 市場規模：タイプ別 (2023-2028)
    • 欧州の前頭側頭障害治療の市場シェア：タイプ別 (2017-2028)
  • 欧州の前頭側頭障害治療 市場規模：アプリケーション別
    • 欧州の前頭側頭障害治療 市場規模：アプリケーション別 (2017-2022)
    • 欧州の前頭側頭障害治療 市場規模：アプリケーション別 (2023-2028)
    • 欧州の前頭側頭障害治療の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の前頭側頭障害治療 市場規模：国別
    • 欧州の前頭側頭障害治療 市場規模：国別 (2017-2022)
    • 欧州の前頭側頭障害治療 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 前頭側頭障害治療 市場規模 (2017-2028)
  • アジア太平洋地域 前頭側頭障害治療 市場規模：タイプ別
    • アジア太平洋地域 前頭側頭障害治療 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 前頭側頭障害治療 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 前頭側頭障害治療の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 前頭側頭障害治療 市場規模：アプリケーション別
    • アジア太平洋地域 前頭側頭障害治療 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 前頭側頭障害治療 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 前頭側頭障害治療の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 前頭側頭障害治療 市場規模：地域別
    • アジア太平洋地域 前頭側頭障害治療 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 前頭側頭障害治療 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの前頭側頭障害治療 市場規模 (2017-2028)
  • ラテンアメリカの前頭側頭障害治療 市場規模：タイプ別
    • ラテンアメリカの前頭側頭障害治療 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの前頭側頭障害治療 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの前頭側頭障害治療の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの前頭側頭障害治療 市場規模：アプリケーション別
    • ラテンアメリカの前頭側頭障害治療 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの前頭側頭障害治療 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの前頭側頭障害治療の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの前頭側頭障害治療 市場規模：国別
    • ラテンアメリカの前頭側頭障害治療 市場規模：国別 (2017-2022)
    • ラテンアメリカの前頭側頭障害治療 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの前頭側頭障害治療 市場規模 (2017-2028)
  • 中東・アフリカの前頭側頭障害治療 市場規模：タイプ別
    • 中東・アフリカの前頭側頭障害治療 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの前頭側頭障害治療 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの前頭側頭障害治療の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの前頭側頭障害治療 市場規模：アプリケーション別
    • 中東・アフリカの前頭側頭障害治療 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの前頭側頭障害治療 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの前頭側頭障害治療の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの前頭側頭障害治療 市場規模：国別
    • 中東・アフリカの前頭側頭障害治療 市場規模：国別 (2017-2022)
    • 中東・アフリカの前頭側頭障害治療 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Eli Lilly
  • Merck
  • Johnson & Johnson
  • AstraZeneca
  • Allergan
  • Mylan

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Frontotemporal Disorders Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Cognitive Enhancers
  • Table 3. Key Players of Antipsychotics
  • Table 4. Key Players of Antidepressants
  • Table 5. Key Players of CNS Stimulants
  • Table 6. Key Players of Others
  • Table 7. Global Frontotemporal Disorders Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 8. Global Frontotemporal Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Frontotemporal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Frontotemporal Disorders Treatment Market Share by Region (2017-2022)
  • Table 11. Global Frontotemporal Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Frontotemporal Disorders Treatment Market Share by Region (2023-2028)
  • Table 13. Frontotemporal Disorders Treatment Market Trends
  • Table 14. Frontotemporal Disorders Treatment Market Drivers
  • Table 15. Frontotemporal Disorders Treatment Market Challenges
  • Table 16. Frontotemporal Disorders Treatment Market Restraints
  • Table 17. Global Frontotemporal Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Frontotemporal Disorders Treatment Revenue Share by Players (2017-2022)
  • Table 19. Global Top Frontotemporal Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frontotemporal Disorders Treatment as of 2021)
  • Table 20. Ranking of Global Top Frontotemporal Disorders Treatment Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Frontotemporal Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Frontotemporal Disorders Treatment Product Solution and Service
  • Table 24. Date of Enter into Frontotemporal Disorders Treatment Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2017-2022)
  • Table 28. Global Frontotemporal Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. Global Frontotemporal Disorders Treatment Revenue Market Share by Type (2023-2028)
  • Table 30. Global Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 31. Global Frontotemporal Disorders Treatment Revenue Share by Application (2017-2022)
  • Table 32. Global Frontotemporal Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. Global Frontotemporal Disorders Treatment Revenue Share by Application (2023-2028)
  • Table 34. North America Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 35. North America Frontotemporal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 36. North America Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 37. North America Frontotemporal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 38. North America Frontotemporal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 39. North America Frontotemporal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 40. Europe Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 41. Europe Frontotemporal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 42. Europe Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 43. Europe Frontotemporal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 44. Europe Frontotemporal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 45. Europe Frontotemporal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Frontotemporal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Frontotemporal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Frontotemporal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Frontotemporal Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 52. Latin America Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 53. Latin America Frontotemporal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 54. Latin America Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 55. Latin America Frontotemporal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 56. Latin America Frontotemporal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 57. Latin America Frontotemporal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Frontotemporal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 64. GlaxoSmithKline Company Details
  • Table 65. GlaxoSmithKline Business Overview
  • Table 66. GlaxoSmithKline Frontotemporal Disorders Treatment Product
  • Table 67. GlaxoSmithKline Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 68. GlaxoSmithKline Recent Developments
  • Table 69. Pfizer Company Details
  • Table 70. Pfizer Business Overview
  • Table 71. Pfizer Frontotemporal Disorders Treatment Product
  • Table 72. Pfizer Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 73. Pfizer Recent Developments
  • Table 74. Sanofi Company Details
  • Table 75. Sanofi Business Overview
  • Table 76. Sanofi Frontotemporal Disorders Treatment Product
  • Table 77. Sanofi Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 78. Sanofi Recent Developments
  • Table 79. Eli Lilly Company Details
  • Table 80. Eli Lilly Business Overview
  • Table 81. Eli Lilly Frontotemporal Disorders Treatment Product
  • Table 82. Eli Lilly Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 83. Eli Lilly Recent Developments
  • Table 84. Merck Company Details
  • Table 85. Merck Business Overview
  • Table 86. Merck Frontotemporal Disorders Treatment Product
  • Table 87. Merck Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 88. Merck Recent Developments
  • Table 89. Johnson & Johnson Company Details
  • Table 90. Johnson & Johnson Business Overview
  • Table 91. Johnson & Johnson Frontotemporal Disorders Treatment Product
  • Table 92. Johnson & Johnson Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 93. Johnson & Johnson Recent Developments
  • Table 94. AstraZeneca Company Details
  • Table 95. AstraZeneca Business Overview
  • Table 96. AstraZeneca Frontotemporal Disorders Treatment Product
  • Table 97. AstraZeneca Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 98. AstraZeneca Recent Developments
  • Table 99. Allergan Company Details
  • Table 100. Allergan Business Overview
  • Table 101. Allergan Frontotemporal Disorders Treatment Product
  • Table 102. Allergan Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 103. Allergan Recent Developments
  • Table 104. Mylan Company Details
  • Table 105. Mylan Business Overview
  • Table 106. Mylan Frontotemporal Disorders Treatment Product
  • Table 107. Mylan Revenue in Frontotemporal Disorders Treatment Business (2017-2022) & (US$ Million)
  • Table 108. Mylan Recent Developments
  • Table 109. Research Programs/Design for This Report
  • Table 110. Key Data Information from Secondary Sources
  • Table 111. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Frontotemporal Disorders Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Cognitive Enhancers Features
  • Figure 3. Antipsychotics Features
  • Figure 4. Antidepressants Features
  • Figure 5. CNS Stimulants Features
  • Figure 6. Others Features
  • Figure 7. Global Frontotemporal Disorders Treatment Market Share by Application: 2021 VS 2028
  • Figure 8. Hospital Pharmacies Case Studies
  • Figure 9. Retail Pharmacies Case Studies
  • Figure 10. Online Pharmacies Case Studies
  • Figure 11. Frontotemporal Disorders Treatment Report Years Considered
  • Figure 12. Global Frontotemporal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 13. Global Frontotemporal Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Frontotemporal Disorders Treatment Market Share by Region: 2021 VS 2028
  • Figure 15. Global Frontotemporal Disorders Treatment Market Share by Players in 2021
  • Figure 16. Global Top Frontotemporal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Frontotemporal Disorders Treatment as of 2021)
  • Figure 17. The Top 10 and 5 Players Market Share by Frontotemporal Disorders Treatment Revenue in 2021
  • Figure 18. North America Frontotemporal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 19. North America Frontotemporal Disorders Treatment Market Size Market Share by Type (2017-2028)
  • Figure 20. North America Frontotemporal Disorders Treatment Market Size Market Share by Application (2017-2028)
  • Figure 21. North America Frontotemporal Disorders Treatment Market Size Share by Country (2017-2028)
  • Figure 22. United States Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Frontotemporal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 25. Europe Frontotemporal Disorders Treatment Market Size Market Share by Type (2017-2028)
  • Figure 26. Europe Frontotemporal Disorders Treatment Market Size Market Share by Application (2017-2028)
  • Figure 27. Europe Frontotemporal Disorders Treatment Market Size Share by Country (2017-2028)
  • Figure 28. Germany Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Frontotemporal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 35. Asia Pacific Frontotemporal Disorders Treatment Market Size Market Share by Type (2017-2028)
  • Figure 36. Asia Pacific Frontotemporal Disorders Treatment Market Size Market Share by Application (2017-2028)
  • Figure 37. Asia Pacific Frontotemporal Disorders Treatment Market Size Share by Region (2017-2028)
  • Figure 38. China Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 44. Latin America Frontotemporal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 45. Latin America Frontotemporal Disorders Treatment Market Size Market Share by Type (2017-2028)
  • Figure 46. Latin America Frontotemporal Disorders Treatment Market Size Market Share by Application (2017-2028)
  • Figure 47. Latin America Frontotemporal Disorders Treatment Market Size Share by Country (2017-2028)
  • Figure 48. Mexico Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Brazil Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Frontotemporal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 51. Middle East and Africa Frontotemporal Disorders Treatment Market Size Market Share by Type (2017-2028)
  • Figure 52. Middle East and Africa Frontotemporal Disorders Treatment Market Size Market Share by Application (2017-2028)
  • Figure 53. Middle East and Africa Frontotemporal Disorders Treatment Market Size Share by Country (2017-2028)
  • Figure 54. Turkey Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Saudi Arabia Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. UAE Frontotemporal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. GlaxoSmithKline Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 58. Pfizer Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 59. Sanofi Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 60. Eli Lilly Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 61. Merck Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 62. Johnson & Johnson Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 63. AstraZeneca Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 64. Allergan Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 65. Mylan Revenue Growth Rate in Frontotemporal Disorders Treatment Business (2017-2022)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed
目次

This research report focuses on the Frontotemporal Disorders Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Frontotemporal Disorders Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Cognitive Enhancers
    • 1.2.3 Antipsychotics
    • 1.2.4 Antidepressants
    • 1.2.5 CNS Stimulants
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Frontotemporal Disorders Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospital Pharmacies
    • 1.3.3 Retail Pharmacies
    • 1.3.4 Online Pharmacies
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Frontotemporal Disorders Treatment Market Perspective (2017-2028)
  • 2.2 Frontotemporal Disorders Treatment Growth Trends by Region
    • 2.2.1 Frontotemporal Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Frontotemporal Disorders Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Frontotemporal Disorders Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Frontotemporal Disorders Treatment Market Dynamics
    • 2.3.1 Frontotemporal Disorders Treatment Industry Trends
    • 2.3.2 Frontotemporal Disorders Treatment Market Drivers
    • 2.3.3 Frontotemporal Disorders Treatment Market Challenges
    • 2.3.4 Frontotemporal Disorders Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Frontotemporal Disorders Treatment Players by Revenue
    • 3.1.1 Global Top Frontotemporal Disorders Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Frontotemporal Disorders Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Frontotemporal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Frontotemporal Disorders Treatment Revenue
  • 3.4 Global Frontotemporal Disorders Treatment Market Concentration Ratio
    • 3.4.1 Global Frontotemporal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Frontotemporal Disorders Treatment Revenue in 2021
  • 3.5 Frontotemporal Disorders Treatment Key Players Head office and Area Served
  • 3.6 Key Players Frontotemporal Disorders Treatment Product Solution and Service
  • 3.7 Date of Enter into Frontotemporal Disorders Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Frontotemporal Disorders Treatment Breakdown Data by Type

  • 4.1 Global Frontotemporal Disorders Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Frontotemporal Disorders Treatment Forecasted Market Size by Type (2023-2028)

5 Frontotemporal Disorders Treatment Breakdown Data by Application

  • 5.1 Global Frontotemporal Disorders Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Frontotemporal Disorders Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Frontotemporal Disorders Treatment Market Size (2017-2028)
  • 6.2 North America Frontotemporal Disorders Treatment Market Size by Type
    • 6.2.1 North America Frontotemporal Disorders Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Frontotemporal Disorders Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Frontotemporal Disorders Treatment Market Share by Type (2017-2028)
  • 6.3 North America Frontotemporal Disorders Treatment Market Size by Application
    • 6.3.1 North America Frontotemporal Disorders Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Frontotemporal Disorders Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Frontotemporal Disorders Treatment Market Share by Application (2017-2028)
  • 6.4 North America Frontotemporal Disorders Treatment Market Size by Country
    • 6.4.1 North America Frontotemporal Disorders Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Frontotemporal Disorders Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Frontotemporal Disorders Treatment Market Size (2017-2028)
  • 7.2 Europe Frontotemporal Disorders Treatment Market Size by Type
    • 7.2.1 Europe Frontotemporal Disorders Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Frontotemporal Disorders Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Frontotemporal Disorders Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Frontotemporal Disorders Treatment Market Size by Application
    • 7.3.1 Europe Frontotemporal Disorders Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Frontotemporal Disorders Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Frontotemporal Disorders Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Frontotemporal Disorders Treatment Market Size by Country
    • 7.4.1 Europe Frontotemporal Disorders Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Frontotemporal Disorders Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Frontotemporal Disorders Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Frontotemporal Disorders Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Frontotemporal Disorders Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Frontotemporal Disorders Treatment Market Size (2017-2028)
  • 9.2 Latin America Frontotemporal Disorders Treatment Market Size by Type
    • 9.2.1 Latin America Frontotemporal Disorders Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Frontotemporal Disorders Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Frontotemporal Disorders Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Frontotemporal Disorders Treatment Market Size by Application
    • 9.3.1 Latin America Frontotemporal Disorders Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Frontotemporal Disorders Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Frontotemporal Disorders Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Frontotemporal Disorders Treatment Market Size by Country
    • 9.4.1 Latin America Frontotemporal Disorders Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Frontotemporal Disorders Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Frontotemporal Disorders Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Frontotemporal Disorders Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Frontotemporal Disorders Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 GlaxoSmithKline
    • 11.1.1 GlaxoSmithKline Company Details
    • 11.1.2 GlaxoSmithKline Business Overview
    • 11.1.3 GlaxoSmithKline Frontotemporal Disorders Treatment Introduction
    • 11.1.4 GlaxoSmithKline Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.1.5 GlaxoSmithKline Recent Developments
  • 11.2 Pfizer
    • 11.2.1 Pfizer Company Details
    • 11.2.2 Pfizer Business Overview
    • 11.2.3 Pfizer Frontotemporal Disorders Treatment Introduction
    • 11.2.4 Pfizer Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.2.5 Pfizer Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Company Details
    • 11.3.2 Sanofi Business Overview
    • 11.3.3 Sanofi Frontotemporal Disorders Treatment Introduction
    • 11.3.4 Sanofi Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.3.5 Sanofi Recent Developments
  • 11.4 Eli Lilly
    • 11.4.1 Eli Lilly Company Details
    • 11.4.2 Eli Lilly Business Overview
    • 11.4.3 Eli Lilly Frontotemporal Disorders Treatment Introduction
    • 11.4.4 Eli Lilly Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.4.5 Eli Lilly Recent Developments
  • 11.5 Merck
    • 11.5.1 Merck Company Details
    • 11.5.2 Merck Business Overview
    • 11.5.3 Merck Frontotemporal Disorders Treatment Introduction
    • 11.5.4 Merck Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.5.5 Merck Recent Developments
  • 11.6 Johnson & Johnson
    • 11.6.1 Johnson & Johnson Company Details
    • 11.6.2 Johnson & Johnson Business Overview
    • 11.6.3 Johnson & Johnson Frontotemporal Disorders Treatment Introduction
    • 11.6.4 Johnson & Johnson Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.6.5 Johnson & Johnson Recent Developments
  • 11.7 AstraZeneca
    • 11.7.1 AstraZeneca Company Details
    • 11.7.2 AstraZeneca Business Overview
    • 11.7.3 AstraZeneca Frontotemporal Disorders Treatment Introduction
    • 11.7.4 AstraZeneca Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.7.5 AstraZeneca Recent Developments
  • 11.8 Allergan
    • 11.8.1 Allergan Company Details
    • 11.8.2 Allergan Business Overview
    • 11.8.3 Allergan Frontotemporal Disorders Treatment Introduction
    • 11.8.4 Allergan Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.8.5 Allergan Recent Developments
  • 11.9 Mylan
    • 11.9.1 Mylan Company Details
    • 11.9.2 Mylan Business Overview
    • 11.9.3 Mylan Frontotemporal Disorders Treatment Introduction
    • 11.9.4 Mylan Revenue in Frontotemporal Disorders Treatment Business (2017-2022)
    • 11.9.5 Mylan Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer